Advanced search
Publication Cover
International Journal of Radiation Biology Volume 95, 2019 - Issue 2
Submit an article Journal homepage
115
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Capacitive hyperthermia as an alternative to brachytherapy in DNA damages of human prostate cancer cell line (DU-145)

Seied Rabi MahdaviRadiation Biology Research Center, Iran University of Medical Sciences, Tehran, Iran; ;Department of Medical Physics, Iran University of Medical Sciences, Tehran, Iran; ORCID Iconhttp://orcid.org/0000-0003-1973-2140View further author information
ORCID Icon,
Azam Janati EsfahaniDepartment of Medical Biotechnology, School of Paramedical Sciences, Qazvin University of Medical Sciences, Qazvin, Iran; Correspondence[email protected] [email protected]
ORCID Iconhttp://orcid.org/0000-0002-3782-4834View further author information
ORCID Icon,
Samideh KhoeiDepartment of Medical Physics, Iran University of Medical Sciences, Tehran, Iran; ORCID Iconhttp://orcid.org/0000-0001-9357-0229View further author information
ORCID Icon,
Mohsen BakhshandehRadiation Technology Department, Allied Medical Sciences FacultyShahid Beheshti University of Medical Sciences, Tehran, Iran; ORCID Iconhttp://orcid.org/0000-0002-6546-7483View further author information
ORCID Icon &
Ali RajabiRadiation Medicine Engineering Department, Shahid Beheshti University, Tehran, Iran.View further author information
Pages 193-200 | Received 31 Aug 2017, Accepted 01 Oct 2018, Published online: 25 Oct 2018

References

  • Baker-Jarvis J, Kim S. 2012. The interaction of radio-frequency fields with dielectric materials at macroscopic to mesoscopic scales. J Res Natl Inst Stand Technol. 117:1–60.
  • Baskar R, Lee KA, Yeo R, Yeoh K-W. 2012. Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 9:193–199.
  • Bergs JWJ, Krawczyk PM, Borovski T, ten Cate R, Rodermond HM, Stap J, Medema JP, Haveman J, Essers J, van Bree C, et al. 2013. Inhibition of homologous recombination by hyperthermia shunts early double strand break repair to non-homologous end-joining. DNA Repair (Amst). 12:38–45.
  • Collins AR, Oscoz AA, Brunborg G, Gaivão I, Giovannelli L, Kruszewski M, Smith CC, Stetina R. 2008. The comet assay: topical issues. Mutagenesis 23:143–151.
  • Datta NR, Eberle B, Puric E, Meister A, Marder D, Tim O, Klimov A, Bodis S. 2016. Is hyperthermia combined with radiotherapy adequate in elderly patients with muscle-invasive bladder cancers? Thermo-radiobiological implications from an audit of initial results. Int J Hyperthermia. 32:390–397.
  • Enmon RM, O'Connor KC, Song H, Lacks DJ, Schwartz DK. 2002. Aggregation kinetics of well and poorly differentiated human prostate cancer cells. Biotechnol Bioeng. 80:580–588.
  • Esfahani AJ, Mahdavi SR, Shiran MB, Khoei S. 2017. The role of radiofrequency hyperthermia in the radiosensitization of human prostate cancer cell line. Cell J (Yakhteh). 19:86–95.
  • Franckena M, Stalpers LJ, Koper PC, Wiggenraad RG, Hoogenraad WJ, van Dijk JD, Wárlám-Rodenhuis CC, Jobsen JJ, van Rhoon GC, van der Zee J. 2008. Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial. Int J Radiat Oncol Biol Phys. 70:1176–1182.
  • Franken NA, Oei AL, Kok HP, Rodermond HM, Sminia P, Crezee J, Stalpers LJ, Barendsen GW. 2013. Cell survival and radiosensitisation: modulation of the linear and quadratic parameters of the LQ model (Review). Int J Oncol. 42:1501–1515.
  • Hall EJ, Giaccia AJ. 2006. Radiobiology for the Radiologist. Philadelphia: Lippincott Williams & Wilkins.
  • Horsman M, Overgaard J. 2002. Overcoming tumour radioresistance resulting from hypoxia. Basic clinical radiobiology. New York: Edward Arnold Publishers Ltd; p. 169–181.
  • Kaver I, Ware JL, Wilson JD, Koontz WW. 1991. Effect of radiation combined with hyperthermia on human prostatic carcinoma cell lines in culture. Urology 38:88–92.
  • Kudzia R, Nahajowski D, Kukiełka AM, Dąbrowski T, Dybek D, Brandys P, Waligórski MPR. 2015. Does microwave interstitial hyperthermia prior to high-dose-rate brachytherapy change prostate volume or therapy plan parameters? Int J Hyperthermia. 31:568–573.
  • Kukiełka AM, Hetnał M, Bereza K. 2016. Evaluation of tolerance and toxicity of high-dose-rate brachytherapy boost combined with interstitial hyperthermia for prostate cancer. Int J Hyperthermia. 32:324–330.
  • Kurosaki H, Sakurai H, Mitsuhashi N, Tamaki Y, Akimoto T, Takahashi T, Furuta M, Saitoh J, Hayakawa K, Niibe H. 2001. Biological cell survival mapping for radiofrequency intracavitary hyperthermia combined with simultaneous high dose‐rate intracavitary irradiation. Cancer Science. 92:95–102.
  • Mahdavi SR, Esfahani AJ, Shiran MB, Khoei S, Estiri N. 2017. Enhanced DNA damages of human prostate cancer cells induced by radiofrequency capacitive hyperthermia pre-and post x-rays: 6 MV versus 15 MV. Cell Journal (Yakhteh). 19:79–85.
  • Matsuya Y, Ohtsubo Y, Tsutsumi K, Sasaki K, Yamazaki R, Date H. 2014. Quantitative estimation of DNA damage by photon irradiation based on the microdosimetric-kinetic model. J Radiat Res. 55:484–493.
  • O’Connor KC, Venczel MZ. 2005. Predicting aggregation kinetics of DU 145 prostate cancer cells in liquid-overlay culture. Biotechnol Lett. 27:1663–1668.
  • Overgaard J. 1980. Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo. Int J Radiat Oncol Biol Phys. 6:1507–1517.
  • Singh NP, McCoy MT, Tice RR, Schneider EL. 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 175:184–191.
  • Spratt DE, Soni PD, McLaughlin PW, Merrick GS, Stock RG, Blasko JC, Zelefsky MJ. 2017. American Brachytherapy Society Task Group Report: combination of brachytherapy and external beam radiation for high-risk prostate cancer. Brachytherapy 16:1–12.
  • Zaorsky NG, Doyle LA, Yamoah K, Andrel JA, Trabulsi EJ, Hurwitz MD, Dicker AP, Den RB. 2014. High dose rate brachytherapy boost for prostate cancer: a systematic review. Cancer Treat Rev. 40:414–425.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.